Skip to content

Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors

Computerized Cognitive Retraining in Breast Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02662335
Enrollment
15
Registered
2016-01-25
Start date
2016-05-31
Completion date
2017-11-30
Last updated
2017-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivor, Stage 0 Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer

Brief summary

This randomized clinical trial studies computerized cognitive retraining in improving cognitive function in breast cancer survivors. Cancer-related cognitive deficits, such as thinking and memory issues, are common among breast cancer survivors. The severity of these cognitive deficits is associated with a significant negative impact on daily function and quality of life. A computerized cognitive retraining method may help researchers find ways to improve cognitive function and quality of life in breast cancer survivors.

Detailed description

PRIMARY OBJECTIVES: I. Evaluate the feasibility and acceptability of a 6-week computerized working memory training program in breast cancer survivors who subjectively report cognitive deficits: evaluate feasibility of study procedures (recruitment and screening procedures, number of participants recruited, screened, and retained, attrition rate and reason, weekly phone calls completed with participants); evaluate the acceptability of an adaptive computerized working memory training intervention (burden, adherence to training schedule, performance level achieved, and participant satisfaction with computerized exercises). SECONDARY OBJECTIVES: I. To evaluate the difference in the posttest means at T2 (week #7) adjusted for T1 (baselines) in the primary working memory outcomes of visuo-spatial working memory (VSWM), visual working memory (VWM), and executive function (EF) as measured by the neuropsychological tests (Rey Auditory Test, Wechsler Adult Intelligence Scale \[WAIS\] IV symbol test, WAIS IV coding test, Delis-Kaplan Executive Function System \[DKFES\] color tests, Trails A and Trails B tests, and WAIS IV Letter and Number sequencing test) and self-report Patient Reported Outcomes Measurement Information System (PROMIS) surveys (Applied Cognition General Concerns Short Form, Applied Cognition Executive Function Short Form, and Functional Assessment of Cancer Therapy \[FACT\] Cognitive Function) between the intervention group and wait control group. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (COMPUTER-ASSISTED COGNITIVE TRAINING): Patients complete a computerized working memory training program (Cogmed) over 35 minutes a day, 5 times a week for 6 weeks. ARM II (WAIT LIST): Patients undergo standard follow-up care for 6 weeks. Following standard follow-up care, patients may complete Cogmed as in the Intervention Group in weeks 7-13.

Interventions

Participate in Cogmed computerized working memory training

OTHERQuestionnaire Administration

Ancillary studies

PROCEDUREStandard Follow-Up Care

Undergo standard follow-up care

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Breast cancer (stage 0, I, II, III), 18 months to 5 years post oncologic therapies of surgery, chemotherapy, and/or radiation therapy (does not exclude current selective estrogen receptor modulators or aromatase inhibitors) * Able to read, write, and speak English * Mini Mental State Exam score greater than or equal to 19 * Have reliable internet and daily access to computer with audio/speakers * Agree to travel to the Seattle Cancer Care Alliance (SCCA) or University of Washington (UW) School of Nursing for 2-3 in person assessments over the 12-13 weeks of the study

Exclusion criteria

* History of multiple cancers * History of central nervous system (CNS) disease, CNS radiation, intrathecal therapy, or CNS surgery * History of traumatic brain injury * Neurologic disorders of stroke, encephalitis, dementia, epilepsy, Alzheimer's disease, Parkinson's disease * Self-report of learning disabilities * Substance addiction * Diagnosis of psychiatric disorders of psychosis, schizophrenia, or bipolar disorder * Mini mental state exam score less than 19 * Previous participation in cognitive training program * Visual impairments such as uncorrected vision or color blindness * Uncorrected hearing impairments * Self-report that they are not pregnant or planning to become pregnant in the next four months * Anticipate moving from the region in the next 4 months * Inability to use a mouse or computer keys to navigate around the computer screen

Design outcomes

Primary

MeasureTime frameDescription
Attrition rateUp to 7 weeksIntervention completion percentage rate and the maximum level achieved for each working memory cognitive domain will be determined for each participant.
Percentage of participants retained in the studyUp to 7 weeksIntervention completion percentage rate and the maximum level achieved for each working memory cognitive domain will be determined for each participant.
Percentage of participants who are recruitedUp to 7 weeksIntervention completion percentage rate and the maximum level achieved for each working memory cognitive domain will be determined for each participant.
Satisfaction, measured by the satisfaction surveyUp to 7 weeksSatisfaction is measured on a 7-point Likert item questionnaire. The frequencies and the mode will be estimated from the satisfaction survey.

Secondary

MeasureTime frameDescription
AnxietyBaseline to up to 7 weeksPROMIS Emotional Distress-Anxiety-Short Form.
CognitionBaseline to up to 7 weeksFACT Cognitive Function, PROMIS Applied Cognition General Concerns Short Form, and Applied Cognition Executive Function Short Form.
DepressionBaseline to up to 7 weeksPROMIS Emotional Distress -Depression Short Form.
Executive FunctionBaseline to up to 7 weeksD-KEFS color word tests, Trails A and B, and Letter-number sequencing.
FatigueBaseline to up to 7 weeksPROMIS Fatigue-Short Form.
Verbal Working MemoryBaseline to up to 7 weeksREY auditory verbal word memory recall and recognition test.
Visuo Spatial Working MemoryBaseline to up to 7 weeksSymbol recognition and coding test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026